Effect of Fenofibrate and Niacin on Intrahepatic Triglyceride Content, Very Low-Density Lipoprotein Kinetics, and Insulin Action in Obese Subjects with Nonalcoholic Fatty Liver Disease

Context: Nonalcoholic fatty liver disease is associated with risk factors for cardiovascular disease, particularly increased plasma triglyceride (TG) concentrations and insulin resistance. Fenofibrate and extended release nicotinic acid (Niaspan) are used to treat hypertriglyceridemia and can affect...

Full description

Saved in:
Bibliographic Details
Main Authors: Fabbrini, Elisa, Mohammed, B. Selma, Korenblat, Kevin M., Magkos, Faidon, McCrea, Jennifer, Patterson, Bruce W., Klein, Samuel
Format: Artigo
Language:Inglês
Published: The Endocrine Society 2010
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2902076/
https://ncbi.nlm.nih.gov/pubmed/20371660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2009-2622
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items